VGHAX
Vanguard Health Care Fund Admiral Shares
1W: -4.1%
1M: -11.2%
3M: -10.2%
YTD: -10.0%
1Y: +2.1%
3Y: +10.4%
5Y: +24.3%
$81.10
-0.13 (-0.16%)
Weekly Expected Move ±2.3%
$77
$79
$81
$83
$85
ETF-Level Metrics
AUM$40.1B
Holdings82
Top 10 Wt42.2%
Beta0.70
% Profitable51%
Coverage97%
Portfolio Valuation
P/E26.2
P/B4.5
P/S3.6
EV/EBITDA16.2
P/FCF31.3
PEG1.90
Profitability & Returns
Gross Margin57.7%
Net Margin13.8%
ROE17.5%
ROA9.5%
ROIC18.0%
Div Yield1.26%
Leverage & Liquidity
Debt/Equity0.29
Debt/Assets0.16
Net Debt/EBITDA—x
Interest Cov19.9x
Current Ratio1.88
Quick Ratio1.48
Growth (YoY)
Revenue+24.9%
Net Income+40.3%
EPS+42.0%
FCF+62.8%
EBITDA+38.9%
Rev CAGR 3Y+19.3%
Quality Scores
Piotroski F6.5
Altman Z8.54
IS Quality72.8
IS Overall61.6
IS Value45.8
Median P/E16.1
Sector Breakdown
5 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 78 | 95.2% | -52.0 |
| Other | 22 | 3.3% | — |
| Consumer Defensive | 1 | 1.3% | 73.8 |
| Financial Services | 2 | 0.1% | 10.6 |
| Basic Materials | 1 | 0.0% | -111.3 |
Smart Money Overlap
8 holdings with signals| Symbol | Company | Weight % | Signals | Badge | Insider Buys | Congress | Since Signal |
|---|---|---|---|---|---|---|---|
| MRK | Merck & Co., Inc. | 4.81% | 4 | Bullish | 11 | 2 | +2.1% |
| UNH | UnitedHealth Group Incorporated | 3.97% | 4 | Bullish | 7 | 5 | -1.7% |
| JNJ | Johnson & Johnson | 2.94% | 4 | Bullish | 12 | 2 | +0.4% |
| ABBV | AbbVie Inc. | 2.79% | 4 | Bullish | 15 | 1 | -4.0% |
| CAH | Cardinal Health, Inc. | 1.67% | 4 | Bullish | 1 | 1 | +0.3% |
| CVS | CVS Health Corporation | 1.45% | 4 | Bullish | 26 | 2 | +2.3% |
| OPCH | Option Care Health, Inc. | 0.45% | 4 | Bullish | 1 | 2 | +4.0% |
| LH | Labcorp Holdings Inc. | 0.44% | 4 | Bullish | 11 | 7 | -2.8% |
Showing 50 of 104 holdings
· Page 1 of 3
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | Eli Lilly & Co | LLY | 10.26% | $4.1B | 3,785,232 | 40.7 | $884.0B | Healthcare |
| 2 | AstraZeneca PLC | AZN.L | 5.76% | $2.3B | 12,329,725 | 30.3 | $237.5B | Healthcare |
| 3 | Merck & Co Inc | MRK | 4.81% | $1.9B | 18,111,825 | 16.5 | $298.8B | Healthcare |
| 4 | UnitedHealth Group Inc | UNH | 3.97% | $1.6B | 4,772,250 | 20.9 | $251.7B | Healthcare |
| 5 | Edwards Lifesciences Corp | EW | 3.22% | $1.3B | 14,972,830 | 44.0 | $47.1B | Healthcare |
| 6 | Johnson & Johnson | JNJ | 2.94% | $1.2B | 5,639,640 | 22.0 | $585.7B | Healthcare |
| 7 | Intuitive Surgical Inc | ISRG | 2.87% | $1.1B | 2,011,562 | 56.2 | $160.5B | Healthcare |
| 8 | GSK PLC | GSK.L | 2.80% | $1.1B | 45,301,487 | 15.1 | $85.8B | Healthcare |
| 9 | AbbVie Inc | ABBV | 2.79% | $1.1B | 4,833,662 | 88.0 | $369.2B | Healthcare |
| 10 | Danaher Corp | DHR | 2.74% | $1.1B | 4,751,135 | 37.4 | $135.1B | Healthcare |
| 11 | Argenx SE | ARGX.BR | 2.48% | $983.6M | 1,165,992 | 40.6 | $40.1B | Healthcare |
| 12 | Vertex Pharmaceuticals Inc | VRTX | 2.45% | $971.2M | 2,142,195 | 28.2 | $111.4B | Healthcare |
| 13 | Cencora Inc | COR | 2.44% | $967.0M | 2,863,084 | 38.8 | $63.2B | Healthcare |
| 14 | Medtronic PLC | MDT | 2.31% | $917.6M | 9,552,320 | 24.1 | $111.2B | Healthcare |
| 15 | UCB SA | UCB.BR | 2.13% | $842.6M | 3,023,965 | 32.3 | $50.4B | Healthcare |
| 16 | Elevance Health Inc | ELV | 1.76% | $696.8M | 1,987,633 | 11.8 | $66.4B | Healthcare |
| 17 | Boston Scientific Corp | BSX | 1.70% | $674.0M | 7,068,493 | 32.2 | $93.2B | Healthcare |
| 18 | Abbott Laboratories | ABT | 1.69% | $668.3M | 5,334,338 | 27.5 | $178.8B | Healthcare |
| 19 | Cardinal Health Inc | CAH | 1.67% | $661.6M | 3,219,274 | 30.3 | $50.4B | Healthcare |
| 20 | Thermo Fisher Scientific Inc | TMO | 1.45% | $576.8M | 995,382 | 27.5 | $182.6B | Healthcare |
| 21 | Roche Holding AG | ROG.SW | 1.45% | $575.8M | 1,394,196 | 19.7 | $256.6B | Healthcare |
| 22 | CVS Health Corp | CVS | 1.45% | $574.2M | 7,234,835 | 52.8 | $93.5B | Healthcare |
| 23 | Galderma Group AG | GALD.SW | 1.35% | $534.2M | 2,623,305 | 73.8 | $36.7B | Consumer Defensive |
| 24 | Agilent Technologies Inc | A | 1.34% | $529.7M | 3,892,828 | 25.3 | $32.7B | Healthcare |
| 25 | Novartis AG | NOVN.SW | 1.32% | $523.0M | 3,795,144 | 21.1 | $235.1B | Healthcare |
| 26 | Alnylam Pharmaceuticals Inc | ALNY | 1.31% | $520.5M | 1,309,033 | 134.4 | $42.3B | Healthcare |
| 27 | Biogen Inc | BIIB | 1.29% | $512.8M | 2,913,639 | 20.1 | $26.0B | Healthcare |
| 28 | United Therapeutics Corp | UTHR | 1.20% | $474.9M | 974,740 | 18.7 | $24.8B | Healthcare |
| 29 | Otsuka Holdings Co Ltd | 4578.T | 1.13% | $446.5M | 7,893,800 | 16.4 | $6.0T | Healthcare |
| 30 | Genmab A/S | GMAB.CO | 1.05% | $417.2M | 1,345,944 | 4.3 | $108.4B | Healthcare |
| 31 | HCA Healthcare Inc | HCA | 1.05% | $416.0M | 891,133 | 16.0 | $105.5B | Healthcare |
| 32 | Chugai Pharmaceutical Co Ltd | 4519.T | 1.05% | $415.1M | 7,912,642 | 33.2 | $15.1T | Healthcare |
| 33 | Daiichi Sankyo Co Ltd | 4568.T | 0.98% | $390.0M | 18,367,566 | 17.5 | $5.3T | Healthcare |
| 34 | Ionis Pharmaceuticals Inc | IONS | 0.76% | $300.9M | 3,803,181 | -31.8 | $12.4B | Healthcare |
| 35 | Bristol-Myers Squibb Co | BMY | 0.72% | $286.8M | 5,317,192 | 17.2 | $121.4B | Healthcare |
| 36 | Astellas Pharma Inc | 4503.T | 0.70% | $275.8M | 20,722,578 | 14.4 | $4.7T | Healthcare |
| 37 | Stryker Corp | SYK | 0.66% | $263.0M | 748,338 | 39.1 | $126.9B | Healthcare |
| 38 | Cytokinetics Inc | CYTK | 0.65% | $257.4M | 4,050,667 | -10.4 | $8.2B | Healthcare |
| 39 | Shionogi & Co Ltd | 4507.T | 0.65% | $257.2M | 14,212,593 | 15.5 | $3.0T | Healthcare |
| 40 | STERIS PLC | STE | 0.65% | $256.7M | 1,012,472 | 30.4 | $21.5B | Healthcare |
| 41 | Eisai Co Ltd | 4523.T | 0.64% | $252.8M | 8,514,317 | 33.0 | $1.4T | Healthcare |
| 42 | ASCENDIS PHARMA A/S - ADR | ASND | 0.59% | $235.3M | 1,103,469 | -53.6 | $14.1B | Healthcare |
| 43 | Avantor Inc | AVTR | 0.54% | $215.5M | 18,803,027 | -10.1 | $5.4B | Healthcare |
| 44 | QIAGEN NV | QGEN | 0.52% | $207.8M | 4,620,121 | 20.1 | $8.5B | Healthcare |
| 45 | Apellis Pharmaceuticals Inc | APLS | 0.52% | $204.8M | 8,153,815 | 227.5 | $5.2B | Healthcare |
| 46 | NOM TSY FICC 01/02/2026 Private | — | 0.50% | $200.0M | 200,000,000 | — | — | — |
| 47 | ICON PLC | ICLR | 0.50% | $199.7M | 1,095,667 | 14.7 | $8.7B | Healthcare |
| 48 | STRUCTURE THERAPEUTICS INC | GPCR | 0.49% | $195.5M | 2,811,254 | -22.4 | $3.1B | Healthcare |
| 49 | Revolution Medicines Inc | RVMD | 0.48% | $189.9M | 2,383,815 | -16.7 | $19.6B | Healthcare |
| 50 | BK AMER MTG FICC 01/02/2026 Private | — | 0.45% | $180.0M | 180,000,000 | — | — | — |